- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05686291
Effectiveness of Hybrid Learning Mode of Volunteer Training
Effectiveness of Hybrid Learning Mode of Volunteer Training: A Randomized Controlled Trial
As the effectiveness of the hybrid volunteer training in Hong Kong is under-studied, this experimental study aims to develop a hybrid learning mode of volunteer training that increase volunteering-related self-efficacy and its associated outcomes among volunteer. In particular, this study compares the efficacy of hybrid volunteer training with the wait-list control group.
The volunteer training will consist of a 6-module online course, followed by 5 face-to-face courses. Each module will consist of the key volunteer training component presented in in written or video format. Materials will be presented interactively to facilitate engagement.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mental illness poses a challenge to public mental health services because of its high prevalence, symptom chronicity, and impacts on patients and society. Although there is a huge amount of need to serve people with mental illness, there is insufficient manpower. There is much empirical evidence to support the volunteer programs for people with mental illness. However, the literature on hybrid volunteer training is mainly focused on teaching and learning in education, and the effectiveness of the hybrid volunteer training in Hong Kong is under-studied. Therefore, The present study aims to compare the efficacy of hybrid volunteer training with the wait-list control group. We hypothesize that (1) participants who receive hybrid volunteer training will increase their self-efficacy of volunteering after the intervention as compared with the wait-list controls; (2) participants from hybrid volunteer training will have better mental health knowledge and less mental health-related stigmatized beliefs and behavior after the intervention as compared with the wait-list controls.
The volunteer training will consist of a 6-module online course, followed by 5 face-to-face courses, incorporating the key volunteer training components, including Keyes theory, bio-psycho-social model, stress bucket model, recovery model and CHIME model. Each module will consist of the key volunteer training component presented in in written or video format. Materials will be presented interactively to facilitate engagement.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong, 999077
- Baptist Oi Kwan Social Service
-
Hong Kong, Hong Kong, 999077
- The Education University of Hong Kong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Hong Kong residents
- Age ≥18 years
- Willing to participate in volunteer service
- Being able to read Chinese
- Have a computer, tablet and/or smartphone device with Internet access
- Have a regular email address
- Willing to give informed consent and comply with the trial protocol
Exclusion Criteria:
- Unable to communicate with Cantonese.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment group
Participants in the treatment condition start the online volunteer training immediately after randomization and completed the online module within 2-week.
Then they are invited to attend the face-to-face training within 1-week.
They will complete the post-intervention assessment right after they finish the face-to-face training, and be invited to participate in an interview.
|
The volunteer training will consist of a 6-module online course, followed by 5 face-to-face courses, incorporating the key volunteer training components, including Keyes theory, bio-psycho-social model, stress bucket model, recovery model and CHIME model.
|
|
No Intervention: Wait-list control group
Participants in the waitlist control group will wait for 4 weeks without the training and then complete the post-intervention assessment.
The waitlist control participants will start training (equivalent to that of the treatment group) immediately after completing the post-intervention assessment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline Assessment in Self-Efficacy Towards Service on the Self-Efficacy Towards Service (SETS) Scale at Post-intervention Assessment and Follow-up Assessment
Time Frame: Before intervention, Immediately after intervention, and 4 weeks after intervention
|
The SETS scale assess the change in a 5-point Likert scale, ranging from strongly disagree (1) to strongly agree (5).
|
Before intervention, Immediately after intervention, and 4 weeks after intervention
|
|
Change from Baseline Assessment in Mental Health-related Knowledge on the Mental Health Knowledge Schedule (MAKS) at Post-intervention Assessment and Follow-up Assessment
Time Frame: Before intervention and Immediately after intervention, and 4 weeks after intervention
|
The MAKS assess the change in a 5-point Likert scale, ranging from strongly disagree (1) to strongly agree (5).
|
Before intervention and Immediately after intervention, and 4 weeks after intervention
|
|
Change from Baseline Assessment in Views of Empowerment on the Empowerment Scale at Post-intervention Assessment and Follow-up Assessment
Time Frame: Before intervention and Immediately after intervention, and 4 weeks after intervention
|
The Empowerment Scale assess the change in a 9-point scale of agreement, ranging from strongly disagree (1) to strongly agree (9).
|
Before intervention and Immediately after intervention, and 4 weeks after intervention
|
|
Change from Baseline Assessment in View of Recovery on the Recovery Scale at Post-intervention Assessment and Follow-up Assessment
Time Frame: Before intervention and Immediately after intervention, and 4 weeks after intervention
|
The Recovery Scale assess the change in a 9-point scale of agreement, ranging from strongly disagree (1) to strongly agree (9).
|
Before intervention and Immediately after intervention, and 4 weeks after intervention
|
|
Change from Baseline Assessment in Mental Health-related Behaviors on the Intended Behaviour subscale of the Reported and Intended Behaviour Scale (RIBS) at Post-intervention Assessment and Follow-up Assessment
Time Frame: Before intervention and Immediately after intervention, and 4 weeks after intervention
|
The RIBS assess the change in a 5-point Likert scale, ranging from strongly disagree to engage in the stated behavior (1) to strongly agree with engaging in the stated behavior (5).
|
Before intervention and Immediately after intervention, and 4 weeks after intervention
|
|
Change from Baseline Assessment in Public Attitudes Toward Mental Illness on the Stigma and Acceptance Scale at Post-intervention Assessment and Follow-up Assessment
Time Frame: Before intervention and Immediately after intervention, and 4 weeks after intervention
|
The Stigma and Acceptance Scale assess the change in a 6-point Likert scale, ranging from strongly disagree (1) to strongly agree (6).
|
Before intervention and Immediately after intervention, and 4 weeks after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline Assessment in Psychological Wellbeing on the World Health Organisation-Five Well-Being Index (WHO-5) at Post-intervention Assessment and Follow-up Assessment
Time Frame: Before intervention and Immediately after intervention, and 4 weeks after intervention
|
The WHO-5 assess the change in a 6-point Likert scale, ranging from at no time (1) to all of the time (6).
|
Before intervention and Immediately after intervention, and 4 weeks after intervention
|
|
Change from Baseline Assessment in Anxiety Symptom on the General Anxiety Disorder-7 (GAD-7) at Post-intervention Assessment and Follow-up Assessment
Time Frame: Before intervention and Immediately after intervention and 4 weeks after intervention
|
The GAD-7 assess the change in a 4-point Likert scale, ranging from not at all (0) to nearly every day (3).
|
Before intervention and Immediately after intervention and 4 weeks after intervention
|
|
Change from Baseline Assessment in Depressive Symptom on the Patient Health Questionnaire-9 (PHQ-9) at Post-intervention Assessment and Follow-up Assessment
Time Frame: Before intervention and Immediately after intervention, and 4 weeks after intervention
|
The PHQ-9 assess the change in a 4-point Likert scale, ranging from not at all (0) to nearly every day (3).
|
Before intervention and Immediately after intervention, and 4 weeks after intervention
|
|
Change from Baseline Assessment in Quality of Life on the Twelve-item short-form (SF-12) health survey at Post-intervention Assessment and Follow-up Assessment
Time Frame: Before intervention and Immediately after intervention, and 4 weeks after intervention
|
The SF-12 assesses the change in a combination of 5-point and 3-point Likert scale, ranging respectively from poor/ never (1) to excellent/ very much (5), and never (1) to very much (3).
|
Before intervention and Immediately after intervention, and 4 weeks after intervention
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Kevin, Ka Shing CHAN, The Education University of Hong Kong
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2021-2022-0403
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteer
-
University Magna GraeciaNot yet recruitingHealthy Volunteer | Healthy Volunteer StudyItaly
-
National Heart, Lung, and Blood Institute (NHLBI)TerminatedHealthy | Healthy Volunteer | HVUnited States
-
AbbVieRecruiting
-
AbbVieNot yet recruiting
-
Advenchen Laboratories Nanjing Ltd.Not yet recruitingHealthy VolunteerChina
-
Hinge BioRecruiting
-
HK inno.N CorporationNot yet recruitingHealthy VolunteerSouth Korea
-
AbbVieRecruitingHealthy VolunteerUnited States
-
Mirador Therapeutics, Inc.Recruiting
-
AbbVieRecruitingHealthy VolunteerUnited States
Clinical Trials on Hybrid volunteer training programme
-
Centre Hospitalier Universitaire DijonCompleted
-
Mark BuhagiarHammondCareCompletedOsteoarthritisAustralia
-
Istanbul University - Cerrahpasa (IUC)Not yet recruiting
-
Universiti Putra MalaysiaEnrolling by invitation
-
Mayo ClinicCompletedPostural Orthostatic Tachycardia SyndromeUnited States
-
University Hospital, LimogesCompleted
-
Chang Gung Memorial HospitalUnknown
-
Heinrich HussleinCompleted
-
EDA UNALCompleted
-
University of Southern DenmarkCompletedSpinal Cord InjuriesDenmark